Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q5RCC2

Entry ID Method Resolution Chain Position Source
AF-Q5RCC2-F1 Predicted AlphaFoldDB

No variants for Q5RCC2

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q5RCC2

No associated diseases with Q5RCC2

16 regional properties for Q5RCC2

Type Name Position InterPro Accession
repeat HAT (Half-A-TPR) repeat 289 - 321 IPR003107-1
repeat HAT (Half-A-TPR) repeat 323 - 355 IPR003107-2
repeat HAT (Half-A-TPR) repeat 384 - 416 IPR003107-3
repeat HAT (Half-A-TPR) repeat 417 - 446 IPR003107-4
repeat HAT (Half-A-TPR) repeat 447 - 476 IPR003107-5
repeat HAT (Half-A-TPR) repeat 554 - 586 IPR003107-6
repeat HAT (Half-A-TPR) repeat 588 - 620 IPR003107-7
repeat HAT (Half-A-TPR) repeat 622 - 654 IPR003107-8
repeat HAT (Half-A-TPR) repeat 656 - 687 IPR003107-9
repeat HAT (Half-A-TPR) repeat 689 - 721 IPR003107-10
repeat HAT (Half-A-TPR) repeat 723 - 755 IPR003107-11
repeat HAT (Half-A-TPR) repeat 757 - 789 IPR003107-12
repeat HAT (Half-A-TPR) repeat 791 - 823 IPR003107-13
domain PRP1 splicing factor, N-terminal 13 - 169 IPR010491
repeat Tetratricopeptide repeat 709 - 742 IPR019734-1
repeat Tetratricopeptide repeat 841 - 874 IPR019734-2

Functions

Description
EC Number
Subcellular Localization
  • Nucleus, nucleoplasm
  • Nucleus speckle
  • Localized in splicing speckles
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

2 GO annotations of cellular component

Name Definition
nuclear speck A discrete extra-nucleolar subnuclear domain, 20-50 in number, in which splicing factors are seen to be localized by immunofluorescence microscopy.
U2-type precatalytic spliceosome A spliceosomal complex that is formed by the recruitment of the preassembled U4/U6.U5 tri-snRNP to the prespliceosome. Although all 5 snRNPs are present, the precatalytic spliceosome is catalytically inactive. The precatalytic spliceosome includes many proteins in addition to those found in the U1, U2 and U4/U6.U5 snRNPs.

No GO annotations of molecular function

Name Definition
No GO annotations for molecular function

1 GO annotations of biological process

Name Definition
mRNA splicing, via spliceosome The joining together of exons from one or more primary transcripts of messenger RNA (mRNA) and the excision of intron sequences, via a spliceosomal mechanism, so that mRNA consisting only of the joined exons is produced.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MNKKKKPFLG MPAPLGYVPG LGRGATGFTT RSDIGPARDA NDPVDDRHAP PGKRTVGDQM
70 80 90 100 110 120
KKNQAADDDD EDLNDTNYDE FNGYAGSLFS SGPYEKDDEE ADAIYAALDK RMDERRKERR
130 140 150 160 170 180
EQREKEEIEK YRMERPKIQQ QFSDLKRKLA EVTEEEWLSI PEVGDARNKR QRNPRYEKLT
190 200 210 220 230 240
PVPDSFFAKH LQTGENHTSV DPRQTQFGGL NTPYPGGLNT PYPGGMTPGL MTPGTGELDM
250 260 270 280 290 300
RKIGQARNTL MDMRLSQVSD SVSGQTVVDP KGYLTDLNSM IPTHGGDIND IKKARLLLKS
310 320 330 340 350 360
VRETNPHHPP AWIASARLEE VTGKLQVARN LIMKGTEMCP KSEDVWLEAA RLQPGDTAKA
370 380 390 400 410 420
VVAQAVRHLP QFVRIYIRAA ELETDIRAKK RVLRKALEHV PNSVRLWKAA VELEEPEDAR
430 440 450 460 470 480
IMLSRAVECC PTSVELWLAL ARLETYENAR KVLNKARENI PTDRHIWITA AKLEEANGNT
490 500 510 520 530 540
QMVEKIIDRA ITSLRANGVE INREQWIQDA EECDRAGSVA TCQAVMRAVI GIGIEEEDRK
550 560 570 580 590 600
HTWMEDADSC VAHNALECAR AIYAYALQVF PSKKSVWLRA AYFGKNHGTR ESLEALLQRA
610 620 630 640 650 660
VAHCPKAEVL WLMGAKSKWL TGDVPAARSI LALAFQANPN SEEIWLAAVK LESENDEYER
670 680 690 700 710 720
ARRLLAKARS SAPTARVFMK SVKLEWVQDN IRAAQDLCEE ALRHYEDFPK LWMMKGQIEE
730 740 750 760 770 780
QKEMMEKARE AYNQGLKKCP HSTPLWLLLS RLEEKIGQLT RTRAILEKSR LKNPKNPGLW
790 800 810 820 830 840
LESVRLEYRA GLKNIANTLM AKALQECPNS GILWSEAIFL EARPQRRTKS VDALKKCEHD
850 860 870 880 890 900
PHVLLAVAKL FWSQRKITKA REWFHRTVKI DSDLGDAWAF FYKFELQHGT EERQEEVRKR
910 920 930 940
CESAEPRHGE LWCAVSEDIA NWQKKIGDIL RLVAGRIKNT F